NEW YORK--(BUSINESS WIRE)--iCell Gene Therapeutics, LLC announced results from a study ongoing at Chengdu Military General Hospital of ICG144, the first CLL1-CD33 Compound CAR T-cell (cCAR) in ...
Please provide your email address to receive an email when new articles are posted on . Researchers have developed a genetically modified form of the immune-stimulating protein interleukin-7 that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback